Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
American Board of Pediatrics Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 9.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC points.
Physicians and other health care professionals seeking 9.25 AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Monday, October 21. A link to the CME evaluation will be emailed to attendees after the conference.
Physicians seeking ABIM and/or ABP MOC points must complete the CME and MOC evaluation by Monday, October 21. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation.
MOC Points will be reported to the ABIM and ABP by the end of October 2019 for attendees who successfully complete the MOC evaluation.
The conference will focus on genomics and the changing approach to diagnostics, management and research in adult and pediatric liver diseases. This course will provide a broad overview of genomic technologies and how they may be applied to understand the genetic underpinnings of rare and complex liver disorders. Attendees will develop a better understanding of the true genomic contribution to liver disease, and how this data can lead to personalized approaches to medical therapy.
Upon completion of this activity, learners will be able to:
This activity was planned in the context of the following ACGME/IOM/IPEC competencies: